BCL2 interacting protein 3 pseudogene 6 (BNIP3P6)

BCL2 interacting protein 3 pseudogene 6 (BNIP3P6) is classified as a pseudogene in the human genome, meaning it closely resembles the protein-coding gene BNIP3 but does not produce a functional protein or have any demonstrated direct biological activity. Pseudogenes like BNIP3P6 are generally remnants of genes that have lost their coding capacity during evolution and are not known to play roles as receptors, enzymes, or therapeutic targets. BNIP3P6 is sometimes referred to using descriptive synonyms, but it is consistently identified as a non-functional region at the genomic level[4][5][8]. Notes: - BNIP3P6 should not be confused with BNIP3, which is a protein-coding member of the Bcl-2 family and is active in apoptosis and cell death pathways[6][9][10]. - There is no evidence BNIP3P6 is used as a therapeutic target, biomarker, or is associated with drugs or clinical mechanisms of action in the biomedical literature or databases. Summary: BNIP3P6 is not a valid therapeutic target or active gene; it is a pseudogene, and as such, it does not have molecular functions, disease roles, or interacting drugs relevant to drug discovery or molecular pharmacology[4][5][8].

Other names

BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 6